Sleep Promotion to Improve Diabetes Management in Adolescents With T1D
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 13 - 17 |
| Updated: | 4/6/2019 |
| Start Date: | October 19, 2017 |
| End Date: | February 5, 2019 |
Sleep Coach: Sleep Promotion to Improve Diabetes Management in Adolescents With T1D
Adolescents with type 1 diabetes (T1D) are at increased risk for problems with adherence and
suboptimal glycemic control, and novel approaches are needed to improve outcomes in this
high-risk population. The majority of adolescents obtain insufficient sleep (defined as <8
hours/night), and sleep disturbance has been significantly associated with poorer adherence
and predicted greater problems with quality of life and worse glycemic control. Yet, no
interventions have addressed sleep in youth with T1D. Working from a biopsychosocial and
contextual model of sleep, the investigators propose to tailor a sleep-promoting intervention
to meet the needs of adolescents with T1D by conducting interviews with to identify the
barriers and facilitators to adequate sleep specific to this population. The sleep-promoting
intervention will be developed and tested, building on successful sleep interventions in
other populations, including components such as limiting caffeine, establishing a media
curfew, and positive bedtime routines, while addressing the needs unique to adolescents with
T1D, such as fear of hypoglycemia. The study will be conducted by a multidisciplinary team,
consisting of Sarah Jaser, PhD, a pediatric psychologist, and two co-investigators, Beth
Malow, MD, MS, a neurologist with specialty in sleep medicine, and Jill Simmons, MD, a
pediatric endocrinologist. Sleep is a potentially modifiable risk factor that may have both a
physiological and behavioral impact on diabetes outcomes. Given the strong associations
between sleep and diabetes outcomes in the preliminary data, and recent evidence from sleep
restriction studies indicating the impact of insufficient sleep on insulin sensitivity,
behavior, and mood, there is reason to believe that a sleep-promoting intervention has the
potential to improve outcomes in adolescents with T1D indirectly by improving adherence and
directly through its effect on metabolic function. Therefore, the proposed study offers a
novel approach to improve adherence, quality of life, and glycemic control in adolescents
with T1D.
suboptimal glycemic control, and novel approaches are needed to improve outcomes in this
high-risk population. The majority of adolescents obtain insufficient sleep (defined as <8
hours/night), and sleep disturbance has been significantly associated with poorer adherence
and predicted greater problems with quality of life and worse glycemic control. Yet, no
interventions have addressed sleep in youth with T1D. Working from a biopsychosocial and
contextual model of sleep, the investigators propose to tailor a sleep-promoting intervention
to meet the needs of adolescents with T1D by conducting interviews with to identify the
barriers and facilitators to adequate sleep specific to this population. The sleep-promoting
intervention will be developed and tested, building on successful sleep interventions in
other populations, including components such as limiting caffeine, establishing a media
curfew, and positive bedtime routines, while addressing the needs unique to adolescents with
T1D, such as fear of hypoglycemia. The study will be conducted by a multidisciplinary team,
consisting of Sarah Jaser, PhD, a pediatric psychologist, and two co-investigators, Beth
Malow, MD, MS, a neurologist with specialty in sleep medicine, and Jill Simmons, MD, a
pediatric endocrinologist. Sleep is a potentially modifiable risk factor that may have both a
physiological and behavioral impact on diabetes outcomes. Given the strong associations
between sleep and diabetes outcomes in the preliminary data, and recent evidence from sleep
restriction studies indicating the impact of insufficient sleep on insulin sensitivity,
behavior, and mood, there is reason to believe that a sleep-promoting intervention has the
potential to improve outcomes in adolescents with T1D indirectly by improving adherence and
directly through its effect on metabolic function. Therefore, the proposed study offers a
novel approach to improve adherence, quality of life, and glycemic control in adolescents
with T1D.
Working from a biopsychosocial and contextual model of sleep, this study will pilot test a
sleep-promoting intervention tailored to meet the needs of adolescents with T1D, building on
successful sleep interventions in other populations, including components such as limiting
caffeine, establishing a media curfew, and positive bedtime routines, while addressing the
needs unique to adolescents with T1D, such as fear of hypoglycemia. The study will be
conducted by a multidisciplinary team, consisting of Sarah Jaser, PhD, a pediatric
psychologist, and two co-investigators, Beth Malow, MD, MS, a neurologist with specialty in
sleep medicine, and Jill Simmons, MD, a pediatric endocrinologist. Sleep is a potentially
modifiable risk factor that may have both a physiological and behavioral impact on diabetes
outcomes. Given the strong associations between sleep and diabetes outcomes in the
preliminary data, and recent evidence from sleep restriction studies indicating the impact of
insufficient sleep on insulin sensitivity, behavior, and mood, there is reason to believe
that a sleep-promoting intervention has the potential to improve outcomes in adolescents with
T1D indirectly by improving adherence and directly through its effect on metabolic function.
Therefore, the proposed study offers a novel approach to improve adherence, quality of life,
and glycemic control in adolescents with T1D.
sleep-promoting intervention tailored to meet the needs of adolescents with T1D, building on
successful sleep interventions in other populations, including components such as limiting
caffeine, establishing a media curfew, and positive bedtime routines, while addressing the
needs unique to adolescents with T1D, such as fear of hypoglycemia. The study will be
conducted by a multidisciplinary team, consisting of Sarah Jaser, PhD, a pediatric
psychologist, and two co-investigators, Beth Malow, MD, MS, a neurologist with specialty in
sleep medicine, and Jill Simmons, MD, a pediatric endocrinologist. Sleep is a potentially
modifiable risk factor that may have both a physiological and behavioral impact on diabetes
outcomes. Given the strong associations between sleep and diabetes outcomes in the
preliminary data, and recent evidence from sleep restriction studies indicating the impact of
insufficient sleep on insulin sensitivity, behavior, and mood, there is reason to believe
that a sleep-promoting intervention has the potential to improve outcomes in adolescents with
T1D indirectly by improving adherence and directly through its effect on metabolic function.
Therefore, the proposed study offers a novel approach to improve adherence, quality of life,
and glycemic control in adolescents with T1D.
Inclusion Criteria:
- Diagnosed with type 1 diabetes for at least 12 months
- Speak and read English
- Report Insufficient sleep (< 8 hours/night most school nights)
Exclusion Criteria:
- Other major health problems or sleep disorders (other than insomnia)
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
